Trial record 1 of 1 for: nct01094691
Previous Study | Return to List | Next Study
Haufen Diagnostic Biomarkers of BK Renal Disease
This study is enrolling participants by invitation only.
University of North Carolina, Chapel Hill
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Volker Nickeleit, MD, University of North Carolina, Chapel Hill
First received: March 25, 2010
Last updated: April 17, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is enrolling participants by invitation only.|
|Estimated Study Completion Date:||December 2019|
|Estimated Primary Completion Date:||July 2019 (Final data collection date for primary outcome measure)|